No effective pharmacological treatment for gluten-related disorders exists to date.
AMYRA is here to fix that.
Overview: Celiac Disease
Celiac disease is an autoimmune reaction triggered by a peptide-induced activation of the immune system in genetically predisposed individuals. The immune reaction mainly takes place in the small intestine, where an inflammation results in acute symptoms such as chronic diarrhoea, bloating, vomiting, and abdominal pain. Furthermore, the damage wrought upon the body’s organs and tissues by this chronic inflammatory condition can lead to more malignant complications such as malnutrition, osteoporosis, and gastrointestinal cancer.
>80 million affected
Non-celiac gluten sensitivity
Overview: Non-Celiac Gluten Sensitivity
Non-Celiac gluten sensitivity is a clinical syndrome that is distinct from celiac disease and wheat allergy. It is characterized by the expression of intestinal and extra intestinal symptoms (imminently) following the ingestion of gluten or other components of wheat. Common symptoms include abdominal pain, bloating, diarrhea and systemic manifestations such as ‘foggy mind’, headache, fatigue, depression and anemia.
480 million affected